drug pricing
Drug pricing news from STAT. Stories include Doctors Without Borders seeking a lower cost for HIV drugs, Genentech slow-walking ovarian cancer therapy, legal cases related to pharmacy benefit managers (PBMs), and the use of continuation patents to curb competition and protect profits.
Latest
BioNTech is having its Pfizer moment
Novo is building a really big computer
STAT Plus: Contineum Therapeutics files for IPO
STAT Plus: What happens when an approved drug doesn’t work?
STAT Plus: Is CAR-T safe for early-stage patients?
STAT Plus: Vertex hits speed bump in getting CRISPR sickle cell therapy covered in U.K.
STAT Plus: Geron’s resurgence might have been short-lived
All Coverage
advertisement
